Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced HBV-Related Hepatocellular Carcinoma (HCC)”

7 trials

Showing 7 of 7 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Large-scale testing (Phase 3)UnknownNCT03236636
What this trial is testing

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Who this might be right for
Advanced HBV-Related Hepatocellular Carcinoma (HCC)
Beijing Shenogen Biomedical Co., Ltd 312
Early research (Phase 1)UnknownNCT05738447
What this trial is testing

Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatocellular Carcinoma
West China Hospital 9
Early research (Phase 1)Not Yet RecruitingNCT07557251
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma

Who this might be right for
Advanced HBV-Related Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 21
Early research (Phase 1)UnknownNCT04032392
What this trial is testing

Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells

Who this might be right for
Hepatocellular Carcinoma
Beijing 302 Hospital 20
Post-approval studies (Phase 4)Study completedNCT07084948
What this trial is testing

Inhibition of HBV Replication and Biological Reversal of Cirrhosis (F3-F4) and HCC by Flavonoids

Who this might be right for
Hepatitis B Virus Infection
Trieu, Nguyen Thi, M.D. 134
Early research (Phase 1)UnknownNCT05339321
What this trial is testing

Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Peking Union Medical College Hospital 36

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation